Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices
Journal of diabetes science and technology - United States
doi 10.1177/1932296819843398
Full Text
Open PDFAbstract
Available in full text
Date
April 11, 2019
Authors
Publisher
SAGE Publications